Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV.
Stefan AdrianHongyu MiaoHan FengAnn ScherzingerGiulia NardiniBarbara BeghettoEnrica RoncagliaGuido LigabueJovana MilicGiovanni GuaraldiJordan E LakeKristine M ErlandsonPublished in: HIV research & clinical practice (2020)
DRV/r was associated with greater fat area and lower density of both fat and muscle, and RAL with less intermuscular psoas fat. Higher density psoas and paraspinal musculature were associated with better physical function, suggesting potential clinical relevance of these findings.